186 related articles for article (PubMed ID: 26771720)
1. How does a drug-coated balloon work? Overview of coating techniques and their impact.
Speck U; Stolzenburg N; Peters D; Scheller B
J Cardiovasc Surg (Torino); 2016 Feb; 57(1):3-11. PubMed ID: 26771720
[TBL] [Abstract][Full Text] [Related]
2. How does a drug-coated balloon work? Overview about coating technologies and their impact.
Speck U; Stolzenburg N; Peters D; Scheller B
J Cardiovasc Surg (Torino); 2015 Dec; ():. PubMed ID: 26681536
[TBL] [Abstract][Full Text] [Related]
3. What are the potential limitations of drug coated balloons and possible ways to overcome.
Werk M
J Cardiovasc Surg (Torino); 2016 Feb; 57(1):23-8. PubMed ID: 26771723
[TBL] [Abstract][Full Text] [Related]
4. Drug coated balloons below-the-knee: just too early?
Fanelli F; Cannavale A
J Cardiovasc Surg (Torino); 2016 Feb; 57(1):18-22. PubMed ID: 26771722
[TBL] [Abstract][Full Text] [Related]
5. Drug-coated balloons: what is the evidence?
Marques L; Hopf-Jensen S; Müller-Hülsbeck S
J Cardiovasc Surg (Torino); 2016 Feb; 57(1):12-7. PubMed ID: 26771721
[TBL] [Abstract][Full Text] [Related]
6. Local drug delivery - the early Berlin experience: single drug administration versus sustained release.
Speck U; Scheller B; Rutsch W; Laule M; Stangl V
EuroIntervention; 2011 May; 7 Suppl K():K17-22. PubMed ID: 22027723
[TBL] [Abstract][Full Text] [Related]
7. Coating and Pharmacokinetic Evaluation of Air Spray Coated Drug Coated Balloons.
Turner EA; Atigh MK; Erwin MM; Christians U; Yazdani SK
Cardiovasc Eng Technol; 2018 Jun; 9(2):240-250. PubMed ID: 29497966
[TBL] [Abstract][Full Text] [Related]
8. Drug Distribution and Basic Pharmacology of Paclitaxel/Resveratrol-Coated Balloon Catheters.
Speck U; Häckel A; Schellenberger E; Kamann S; Löchel M; Clever YP; Peters D; Scheller B; Trog S; Bettink S
Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1599-1610. PubMed ID: 29968090
[TBL] [Abstract][Full Text] [Related]
9. New developments with drug-coated balloons.
Tepe G
J Cardiovasc Surg (Torino); 2016 Feb; 57(1):1-2. PubMed ID: 26771719
[No Abstract] [Full Text] [Related]
10. Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model.
Yazdani SK; Pacheco E; Nakano M; Otsuka F; Naisbitt S; Kolodgie FD; Ladich E; Rousselle S; Virmani R
Catheter Cardiovasc Interv; 2014 Jan; 83(1):132-40. PubMed ID: 23703778
[TBL] [Abstract][Full Text] [Related]
11. Experimental evaluation of pharmacokinetic profile and biological effect of a novel paclitaxel microcrystalline balloon coating in the iliofemoral territory of swine.
Buszman PP; Milewski K; Zurakowski A; Pajak J; Jelonek M; Gasior P; Peppas A; Tellez A; Granada JF; Buszman PE
Catheter Cardiovasc Interv; 2014 Feb; 83(2):325-33. PubMed ID: 23703720
[TBL] [Abstract][Full Text] [Related]
12. Novel, vessel anatomy adjusting drug-coated balloon-Preclinical evaluation in peripheral porcine arteries.
Bienek S; Kusmierczuk M; Mittag A; Bettink S; Scheller B
Catheter Cardiovasc Interv; 2020 Feb; 95(2):319-328. PubMed ID: 31696642
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of gadolinium-BOPTA uptake into the vessel wall during magnetic resonance (MR)-guided angioplasty of the peripheral arteries with a paclitaxel/gadolinium-BOPTA-coated balloon: an experimental study at 3 Tesla.
Neizel M; Ruebben A; Weiss N; Günther RW; Kelm M; Krombach GA
Rofo; 2014 Apr; 186(4):388-93. PubMed ID: 24142436
[TBL] [Abstract][Full Text] [Related]
14. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of neo-intimal hyperplasia in porcine coronary arteries utilizing a novel paclitaxel-coated scoring balloon catheter.
Cremers B; Schmitmeier S; Clever YP; Gershony G; Speck U; Scheller B
Catheter Cardiovasc Interv; 2014 Dec; 84(7):1089-98. PubMed ID: 24259380
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of paclitaxel coatings for delivery via drug-coated balloons.
Kempin W; Kaule S; Reske T; Grabow N; Petersen S; Nagel S; Schmitz KP; Weitschies W; Seidlitz A
Eur J Pharm Biopharm; 2015 Oct; 96():322-8. PubMed ID: 26318979
[TBL] [Abstract][Full Text] [Related]
17. Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients.
Radke PW; Joner M; Joost A; Byrne RA; Hartwig S; Bayer G; Steigerwald K; Wittchow E
EuroIntervention; 2011 Oct; 7(6):730-7. PubMed ID: 21986331
[TBL] [Abstract][Full Text] [Related]
18. A novel constrained, paclitaxel-coated angioplasty balloon catheter.
Cremers B; Binyamin G; Clever YP; Seifert P; Konstantino E; Kelsch B; Bienek S; Speck U; Scheller B
EuroIntervention; 2017 Apr; 12(17):2140-2147. PubMed ID: 27973329
[TBL] [Abstract][Full Text] [Related]
19. Coating of intravascular balloon with paclitaxel prevents constrictive remodeling of the dilated porcine femoral artery due to inhibition of intimal and media fibrosis.
Pavo N; Samaha E; Sabdyusheva I; von Strandmann RP; Stahnke S; Plass CA; Zlabinger K; Lukovic D; Jambrik Z; Pavo IJ; Bergler-Klein J; Gray WA; Maurer G; Gyöngyösi M
J Mater Sci Mater Med; 2016 Aug; 27(8):131. PubMed ID: 27388164
[TBL] [Abstract][Full Text] [Related]
20. 3D modelling of drug-coated balloons for the treatment of calcified superficial femoral arteries.
Colombo M; Corti A; Berceli S; Migliavacca F; McGinty S; Chiastra C
PLoS One; 2021; 16(10):e0256783. PubMed ID: 34634057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
